Neoadjuvant FOLFOXIRI for locally advanced rectal cancer: A retrospective analysis focusing on long-term anal preservation

To investigate the safety and efficacy of FOLFOXIRI as neoadjuvant chemotherapy (NAC) for locally advanced rectal cancer (LARC). The outcomes of preoperative and perioperative treatments, as well as long-term outcomes, were retrospectively compared between 26 patients who underwent FOLFOXIRI as NAC...

Description complète

Détails bibliographiques

Auteurs principaux:	Ryohei Shoji, Fuminori Teraishi, Yuki Matsumi, Yusuke Yoshida, Nobuhiko Kanaya, Kunitoshi Shigeyasu, Yoshitaka Kondo, Yoshiko Mori, Shunsuke Kagawa, Toshiyoshi Fujiwara
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2025-01-01
Collection:	Cancer Treatment and Research Communications
Sujets:	Locally advanced rectal cancer Neoadjuvant chemotherapy FOLFOXIRI Late pelvic toxicity
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2468294225001856
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!